Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Clinical trial NCT06399835 · RECRUITING

Trial details

NCT number: NCT06399835
Sponsor: Seoul National University Bundang Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-02-01
Primary completion: 2026-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.